Related Experiment Video
Updated: Dec 6, 2025

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
Published on: November 4, 2022
A Multicompartment Human Kidney Proximal Tubule-on-a-Chip Replicates Cell Polarization-Dependent Cisplatin Toxicity
Tom T G Nieskens1, Mikael Persson1, Edward J Kelly1
1CVRM Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden (T.T.G.N., M.P., A.-K.S.) and Department of Pharmaceutics and Kidney Research Institute, University of Washington, Seattle, Washington (E.J.K.).
Abstract:
Drug-induced kidney injury is a major clinical problem and causes drug attrition in the pharmaceutical industry. To better predict drug-induced kidney injury, kidney in vitro cultures with enhanced physiologic relevance are developed. To mimic the proximal tubule, the main site of adverse drug reactions in the kidney, human-derived renal proximal tubule epithelial cells (HRPTECs) were injected in one of the channels of dual-channel Nortis chips and perfused for 7 days. Tubes of HRPTECs demonstrated expression of tight junction protein 1 (zona occludens-1), lotus lectin, and primary cilia with localization at the apical membrane, indicating an intact proximal tubule brush border. Gene expression of cisplatin efflux transporters multidrug and toxin extrusion transporter (MATE) 1 (SLC47A1) and MATE2-k (SLC47A2) and megalin endocytosis receptor increased 19.9 ± 5.0-, 23.2 ± 8.4-, and 106 ± 33-fold, respectively, in chip cultures compared with 2-dimensional cultures. Moreover, organic cation transporter 2 (OCT2) (SLC22A2) was localized exclusively on the basolateral membrane. When infused from the basolateral compartment, cisplatin (25 µM, 72 hours) induced toxicity, which was evident as reduced cell number and reduced barrier integrity compared with vehicle-treated chip cultures. Coexposure with the OCT2 inhibitor cimetidine (1 mM) abolished cisplatin toxicity. In contrast, infusion of cisplatin from the apical compartment did not induce toxicity, which was in line with polarized localization of cisplatin uptake transport proteins, including OCT2. In conclusion, we developed a dual channel human kidney proximal tubule-on-a-chip with a polarized epithelium, restricting cisplatin sensitivity to the basolateral membrane and suggesting improved physiologic relevance over single-compartment models. Its implementation in drug discovery holds promise to improve future in vitro drug-induced kidney injury studies. SIGNIFICANCE STATEMENT: Human-derived kidney proximal tubule cells retained characteristics of epithelial polarization in vitro when cultured in the kidney-on-a-chip, and the dual-channel construction allowed for drug exposure using the physiologically relevant compartment. Therefore, cell polarization-dependent cisplatin toxicity could be replicated for the first time in a kidney proximal tubule-on-a-chip. The use of this physiologically relevant model in drug discovery has potential to aid identification of safe novel drugs and contribute to reducing attrition rates due to drug-induced kidney injury.
Insights
A novel kidney-on-a-chip model using human cells replicates proximal tubule function, enabling accurate prediction of drug-induced kidney injury by showing cisplatin toxicity only when administered to the basolateral side.
Area of Science:
- Biotechnology
- Renal Physiology
- Drug Discovery
Background:
- Drug-induced kidney injury (DIKI) is a significant clinical challenge and a major cause of drug attrition in pharmaceutical development.
- Existing in vitro models often lack the physiological relevance needed to accurately predict DIKI.
- The kidney proximal tubule is a primary site for adverse drug reactions.
Purpose of the Study:
- To develop and validate a human kidney proximal tubule-on-a-chip model with enhanced physiological relevance for predicting DIKI.
- To assess the polarized expression and function of key transporters in the chip model.
- To evaluate the cell polarization-dependent toxicity of cisplatin in this advanced in vitro system.
Main Methods:
- Human-derived renal proximal tubule epithelial cells (HRPTECs) were cultured in a dual-channel Nortis chip for 7 days to form polarized tubules.
- The model's integrity and brush border characteristics were confirmed through protein expression and localization analysis.
- Gene expression of key drug transporters (MATE1, MATE2-k, megalin, OCT2) was quantified.
- Cisplatin toxicity was assessed following basolateral or apical administration, with and without the OCT2 inhibitor cimetidine.
Main Results:
- The HRPTEC cultures in the chip exhibited characteristics of an intact proximal tubule brush border, including expression of tight junction protein 1 and primary cilia.
- Significant upregulation of efflux transporters (MATE1, MATE2-k) and endocytosis receptor (megalin) was observed compared to 2D cultures.
- Organic cation transporter 2 (OCT2) showed exclusive basolateral localization.
- Basolateral cisplatin infusion induced significant toxicity (reduced cell number, compromised barrier integrity), which was abrogated by cimetidine.
- Apical cisplatin infusion did not cause toxicity, consistent with the polarized localization of uptake transporters.
Conclusions:
- A dual-channel human kidney proximal tubule-on-a-chip model was successfully developed, demonstrating epithelial polarization and physiological relevance.
- The model accurately replicated cell polarization-dependent cisplatin toxicity, restricted to the basolateral membrane due to OCT2 localization.
- This chip model offers a promising platform for improving in vitro DIKI studies in drug discovery, potentially reducing attrition rates.

